HGC Investment Management’s NRX Pharmaceuticals NRXP Stock Holding History

HGC Investment Management’s Portfolio NRXP Stock Details NRXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-46,967	Closed	-$4.86M	–	141
2019 Q1	$4.86M	Hold	46,967	–	–	1.13%	34
2018 Q4	$4.79M	Sell	46,967 -1,159	-2%	-$117K	1.16%	34
2018 Q3	$4.82M	Buy	48,126 +500	+1%	+$49.8K	1.3%	26
2018 Q2	$4.72M	Buy	47,626 +5,100	+12%	+$503K	1.55%	25
2018 Q1	$4.18M	Buy	42,526 +2,034	+5%	+$198K	1.52%	27
2017 Q4	$3.93M	Buy	+40,492	New	+$3.92M	1.46%	27

Other funds holding NRXP

MSU

Mizuho Securities USA New York $4.24B AUM 22.54% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

HGC Investment Management's NRXP Position: Q2 2019 in Review

HGC Investment Management sold out of NRX Pharmaceuticals (NRXP) in Q2 2019, closing a stake of 46,967 shares — an estimated $4.86M sold.

HGC Investment Management first reported a position in NRXP in Q4 2017 and held it in 6 quarters. The position peaked at $4.86M in Q1 2019. 17 funds tracked by Wall St. Rank hold NRXP as of Q2 2019.

HGC Investment Management reported no remaining NRX Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
HGC Investment Management sold 46,967 NRX Pharmaceuticals shares in Q2 2019, an estimated $4.86M.
HGC Investment Management first reported a position in NRX Pharmaceuticals in Q4 2017 and held it in 6 quarters.
HGC Investment Management's NRX Pharmaceuticals position peaked at $4.86M in Q1 2019.
17 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q2 2019.

Based on HGC Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.